Rezultati pretraživanja
  1. 28. lis 2019.

    We had some M&M’s as a tasty reminder that we’re getting closer to our December 4th PDUFA date

  2. 24. lis 2019.

    got in the spooky spirit a few days early proving that Halloween isn’t a day, it’s a state of mind

  3. 11. kol 2017.

    Wrapping up our first Career Week & we’re feeling motivated + inspired by the breadth of experience of our colleagues!

  4. 23. pro 2019.

    Since 2009, has supported and we’re blown away by the support from our employees during annual toy drives. The boxes may not look festive, but these unwrapped gifts will help brighten the holidays for Cambridge kids. Happy holidays!

  5. 21. pro 2019.

    The annual Pool Tournament had some holiday spirit this year thanks to its organizer, Lee! Congratulations to our winner, Travis, as well as our runner up/fearless leader, Habib.

  6. 20. pro 2019.

    Congratulations to the Team-ACE award recipients. Extremely proud of the Technical Ops team for their 2019 accomplishments and their commitment to patients👩‍🔬👨🏽‍🔬 👏

  7. 29. lip 2018.

    "Celgene already owned about a 13% equity stake in Acceleron Pharma as of Dec. 31, 2017. Whether Celgene decides to acquire Acceleron Pharma outright at some point is anyone's guess, but given the peak sales opportunity, it's possible" as reported by the Motely Fool

  8. 6. svi 2016.

    - Acceleron Pharma Inc Position Increased by TIAA CREF Investment Management LLC

  9. 31. sij 2019.

    eXLearn 2019 is official! Sept 4-5 in Indianapolis, IN We have two great keynotes this year: and *And* + will facilitate a full day design thinking preconference workshop.

  10. 25. lis 2019.

    In honor of , wants to acknowledge the community of patients, caregivers, and physicians who are motivated to find a treatment for this rare blood disorder. Your voice counts – help spread awareness!

  11. 20. pro 2019.

    You might have spied these folks if you attended last week’s conference! With such amazing speakers as and , it’s no wonder this picture has so many smiling faces!

  12. 27. lip 2016.

    - Weekly Research Analysts' Ratings Changes for Acceleron Pharma

  13. 25. ruj 2018.

    At , we are focused on harnessing the power of the TGF-beta superfamily and its role in cellular growth and repair. Learn more here:

  14. 18. kol 2017.

    We had a great time volunteering @ the Summer Camp yesterday, where we met some rock star patients & modeled fun tattoos!

  15. 17. svi 2017.

    Acceleron Pharma, Inc. Initiated Coverage by Goldman Sachs (Ranked 29th) to Sell with $20PT

  16. 28. velj 2018.

    Acceleron Pharma Inc Reiterated Rating by Barclays Capital (Ranked 28th) to Overweight with $54PT

  17. 15. ruj 2017.

    Acceleron Pharma Inc Initiated Coverage by RBC Capital Mkts (Ranked 60th) to Sector Perform with $44PT

  18. 10. ruj 2018.

    Acceleron Pharma Inc Reiterated Rating by Morgan Stanley (Ranked 32nd) to Equal-Weight with $55PT

  19. 25. tra 2017.

    - Somewhat Favorable Press Coverage Very Unlikely to Impact Acceleron Pharma

  20. 29. sij

    Piper Sandler Lowers Acceleron Pharma FY2022 Earnings Estimates to $1.28 EPS (Previously $1.31).

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.